Covered recipient · General Payments record
DIANE WENTLING
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,245.22
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $743.92 | 16 |
| Education | $174.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $238.96 | 2 |
| ABBVIE INC. | $209.79 | 8 |
| Astellas Pharma US Inc | $174.98 | 2 |
| Ipsen Biopharmaceuticals, Inc | $147.60 | 3 |
| EISAI INC. | $134.48 | 2 |
| ADC Therapeutics America, Inc. | $13.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $108.66 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108396959 | CMS |
| ABBVIE INC. | $16.62 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108396961 | CMS |
| ABBVIE INC. | $13.30 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108396963 | CMS |
| ABBVIE INC. | $14.38 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108396965 | CMS |
| ABBVIE INC. | $14.87 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108396967 | CMS |
| ABBVIE INC. | $6.91 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108396969 | CMS |
| ABBVIE INC. | $28.76 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108396971 | CMS |
| ABBVIE INC. | $6.29 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108396973 | CMS |
| ADC Therapeutics America, Inc. | $13.09 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121193375 | CMS |
| Astellas Pharma US Inc | $99.99 | 09/25/2024 | Education | Undisputed | 01/23/2026 | 1139540338 | CMS |
| Astellas Pharma US Inc | $74.99 | 10/03/2024 | Education | Undisputed | 01/23/2026 | 1139546225 | CMS |
| AstraZeneca Pharmaceuticals LP | $114.30 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105209003 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.66 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105487591 | CMS |
| Eisai Inc. | $20.18 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110799963 | CMS |
| Eisai Inc. | $114.30 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110799965 | CMS |
| Ipsen Biopharmaceuticals, Inc | $126.27 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091966458 | CMS |
| Ipsen Biopharmaceuticals, Inc | $2.50 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091966460 | CMS |
| Ipsen Biopharmaceuticals, Inc | $18.83 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091966462 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.